A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices
Maintaining the accuracy and efficiency of AAV genome titer quantification is crucial in gene therapy manufacturing. This 14-minute video presentation, accompanied by a poster summary, explores a novel PCR-free assay that enhances speed, reliability, and flexibility. By utilizing DNA hybridization, immunochemistry, and bio-layer interferometry (BLI), this assay simplifies titer quantification and improves workflow efficiency. NEW INTERACTIVE FORMAT Listen to our expert speaker. Watch the video. Read the summary. Focus in on the data. Download the PDF. It has never been easier to quickly access the information you want. All in one place—at the click of a button.
Authors
- Wai Choi
Institutions
- Bio-Medical Science (South Korea) (KR)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2025-04-04
- DOI
- https://doi.org/10.18609/cgti.2025.041
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00